Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well differentiated thyroid cancer

D. P. Aiello, Andrea Manni

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Measurement of the serum thyroglobulin level may be more sensitive than total-body scan using sodium iodide 131 for detecting recurrences from well-differentiated thyroid cancer. We have evaluated the merit of these two methods through a retrospective chart review of patients followed up at the Milton S. Hershey Medical Center, Hershey, Pa. We found that in 17 (45%) of 38 follow-up visits, the presence of interfering antibodies prevented the measurement of serum thyroglobulin levels. Furthermore, such determination was less sensitive than iodine 131 total-body scan in detecting residual thyroid tissue and/or cancer in the neck area. We concluded that iodine 131 total-body scan is the preferable method of follow-up, particularly when the goal of therapy is complete ablation of thyroid tissue.

Original languageEnglish (US)
Pages (from-to)437-439
Number of pages3
JournalArchives of Internal Medicine
Volume150
Issue number2
DOIs
StatePublished - Mar 5 1990

Fingerprint

Thyroglobulin
Thyroid Neoplasms
Iodine
Thyroid Gland
Sodium Iodide
Head and Neck Neoplasms
Serum
Recurrence
Antibodies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

@article{eed328622ae94e0d909080c2baa8ed6d,
title = "Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well differentiated thyroid cancer",
abstract = "Measurement of the serum thyroglobulin level may be more sensitive than total-body scan using sodium iodide 131 for detecting recurrences from well-differentiated thyroid cancer. We have evaluated the merit of these two methods through a retrospective chart review of patients followed up at the Milton S. Hershey Medical Center, Hershey, Pa. We found that in 17 (45{\%}) of 38 follow-up visits, the presence of interfering antibodies prevented the measurement of serum thyroglobulin levels. Furthermore, such determination was less sensitive than iodine 131 total-body scan in detecting residual thyroid tissue and/or cancer in the neck area. We concluded that iodine 131 total-body scan is the preferable method of follow-up, particularly when the goal of therapy is complete ablation of thyroid tissue.",
author = "Aiello, {D. P.} and Andrea Manni",
year = "1990",
month = "3",
day = "5",
doi = "10.1001/archinte.150.2.437",
language = "English (US)",
volume = "150",
pages = "437--439",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "2",

}

Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well differentiated thyroid cancer. / Aiello, D. P.; Manni, Andrea.

In: Archives of Internal Medicine, Vol. 150, No. 2, 05.03.1990, p. 437-439.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well differentiated thyroid cancer

AU - Aiello, D. P.

AU - Manni, Andrea

PY - 1990/3/5

Y1 - 1990/3/5

N2 - Measurement of the serum thyroglobulin level may be more sensitive than total-body scan using sodium iodide 131 for detecting recurrences from well-differentiated thyroid cancer. We have evaluated the merit of these two methods through a retrospective chart review of patients followed up at the Milton S. Hershey Medical Center, Hershey, Pa. We found that in 17 (45%) of 38 follow-up visits, the presence of interfering antibodies prevented the measurement of serum thyroglobulin levels. Furthermore, such determination was less sensitive than iodine 131 total-body scan in detecting residual thyroid tissue and/or cancer in the neck area. We concluded that iodine 131 total-body scan is the preferable method of follow-up, particularly when the goal of therapy is complete ablation of thyroid tissue.

AB - Measurement of the serum thyroglobulin level may be more sensitive than total-body scan using sodium iodide 131 for detecting recurrences from well-differentiated thyroid cancer. We have evaluated the merit of these two methods through a retrospective chart review of patients followed up at the Milton S. Hershey Medical Center, Hershey, Pa. We found that in 17 (45%) of 38 follow-up visits, the presence of interfering antibodies prevented the measurement of serum thyroglobulin levels. Furthermore, such determination was less sensitive than iodine 131 total-body scan in detecting residual thyroid tissue and/or cancer in the neck area. We concluded that iodine 131 total-body scan is the preferable method of follow-up, particularly when the goal of therapy is complete ablation of thyroid tissue.

UR - http://www.scopus.com/inward/record.url?scp=0025060934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025060934&partnerID=8YFLogxK

U2 - 10.1001/archinte.150.2.437

DO - 10.1001/archinte.150.2.437

M3 - Article

C2 - 2105703

AN - SCOPUS:0025060934

VL - 150

SP - 437

EP - 439

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 2

ER -